Evidence map›Paper›PMID 36712813›Full record

ArticleHealth science reports2023

A novel strategy to optimize critical information on over the counter labels for older adults.

Mark W Becker, Deborah A Kashy, Alyssa Harben, Krishnaa Venkatesan, Andrew Rodriguez, Matt Kebede, Beth Martin, Robert Breslow, Laura Bix

Registry-linked trialAbstract read
In one paragraph

Article in Health science reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04345731 (Over-the-counter), which is not on this map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04345731 nacompletednot on this map

Over-the-counter (OTC) Labels for Older Adults

TypeinterventionalSponsorMichigan State UniversityRan2018 to 2023Enrolled420ConditionsAdverse Drug EventArmsOver the counter drug labels
3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mark W BeckerDepartment of Psychology, Cognitive Neurology Group Michigan State University East Lansing Michigan USA.
Deborah A KashyDepartment of Psychology, Cognitive Neurology Group Michigan State University East Lansing Michigan USA.
Alyssa HarbenSchool of Packaging Michigan State University East Lansing Michigan USA.
Krishnaa VenkatesanSchool of Packaging Michigan State University East Lansing Michigan USA.
Andrew RodriguezDepartment of Psychology, Cognitive Neurology Group Michigan State University East Lansing Michigan USA.
Matt KebedeDepartment of Psychology, Cognitive Neurology Group Michigan State University East Lansing Michigan USA.
Beth MartinSchool of Pharmacy University of Wisconsin Madison Wisconsin USA.
Robert BreslowSchool of Pharmacy University of Wisconsin Madison Wisconsin USA.
Laura BixSchool of Packaging Michigan State University East Lansing Michigan USA.ORCID 0000-0002-5779-7474

Funding

AHRQ HHS R01 HS025386
6 · The paper itself

Abstract

Background and Aims: Labels designed to communicate critical information are paramount for the safe and effective use of over-the-counter medications; in recognition of this, the content and formatting of over the counter (OTC) labels sold in interstate commerce has been regulated for decades. Yet, available studies suggest that consumers frequently rely on limited information during decision making, failing to access the information required in the Drug Facts Label. This is particularly important for older consumers, who are at greater risk for adverse reactions to medicines. In two experiments we objectively evaluate how novel label designs that employ highlighting and a warning label placed on the package's front impact older consumers' attention to, and use of, critical information. Methods: In Experiment 1, 68 OTC patients (65+) engaged with a computer-based task answering yes/no scenario-based questions about a drug's appropriateness. In Experiment 2, 63 OTC patients (65+) conducted a forced-choice task where one of two drugs presented on a computer screen was appropriate for a provided scenario while the other was not. Both tasks required participants to access and use critical label information (i.e., warnings or active ingredients) to respond correctly. Dependent variables analyzed were the proportion of correct responses and time to correct response. Results: Highlighting or placing critical information on the front of the package significantly improved response accuracy and time to correct response in Experiment 1 as compared to responses utilizing the standard label. For Experiment 2, participants were faster and more accurate when critical information was highlighted. Conclusions: Results provide direct measures of the efficacy of novel labeling strategies. This information is relevant for regulations which dictate label design in ways that enhance ease and safety of use of medications for older adults.

Indexed as

improved adherencemedication errorpatient‐centered designpatient safety

Identifiers

PMID36712813
PMCPMC9874361

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.